A Health Crisis Looms: Alarming Rise in Chronic Liver Disease Predicted by 2050 focustechnica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focustechnica.com Daily Mail and Mail on Sunday newspapers.
Arbutus Biopharma (ABUS) Announces 2024 Corporate Objectives and Provides Financial Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Additional data from two on-going Phase 2a clinical trials evaluating imdusiran, our RNAi therapeutic, as a cornerstone therapy in combination with other compounds expected in 2024 Initiation of a.
Take Homes in HCV healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
US Food and Drug Administration has granted Priority Review for New Drug Application for elafibranor in PBC, and European Medicine Agency has also validated the Marketing Authorization Application .